Lead Product(s): BL-001
Therapeutic Area: Neurology
Highest Development Status: Undisclosed Product Type: Undisclosed
Partner/Sponsor/Collaborator: ALS Association
Deal Size: $0.5 million Upfront Cash: Undisclosed
Deal Type: Funding March 17, 2020
Bloom is leveraging its GOLD platform in combination with strong pre-clinical data to advance a new generation of therapeutics aimed at managing gut microbiota.